These results suggest that, though SMAD4 is a direct repressor of PD-L1 in tumor cells, by enhancing the recruitment of T-cells and raising local IFNγ levels, SMAD4 functions as an indirect inducer of PD-L1. Here, CD274 is linked to neoplasm.